Compare ALEC & PAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALEC | PAI |
|---|---|---|
| Founded | 2013 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.2M | 118.3M |
| IPO Year | 2019 | N/A |
| Metric | ALEC | PAI |
|---|---|---|
| Price | $1.45 | $12.62 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 25.0K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.78% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,048,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $155.87 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.26 | N/A |
| 52 Week Low | $0.87 | $10.59 |
| 52 Week High | $3.40 | $12.63 |
| Indicator | ALEC | PAI |
|---|---|---|
| Relative Strength Index (RSI) | 51.90 | 61.46 |
| Support Level | $1.34 | $12.37 |
| Resistance Level | $1.49 | $12.55 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 72.22 | 91.99 |
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. The company designed as a long-term investment and not as a trading vehicle. The fund seeks a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. Its portfolio is invested in securities which may be convertible into or exchangeable for, or carry warrants to purchase, common stock or other equity interests; and preferred stock.